Decreased Fas expression in advanced-stage bladder cancer is not related to p53 status
- 1 February 2004
- Vol. 63 (2) , 392-397
- https://doi.org/10.1016/j.urology.2003.08.023
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Epigenetic changes in tumor Fas levels determine immune escape and response to therapyCancer Cell, 2002
- Fas function and tumor progression: Use it and lose itCancer Cell, 2002
- Death and anti-death: tumour resistance to apoptosisNature Reviews Cancer, 2002
- A matter of life and deathCancer Cell, 2002
- Apoptosis: A Link between Cancer Genetics and ChemotherapyPublished by Elsevier ,2002
- Hypermethylation of the tumor necrosis factor receptor superfamily 6 (APT1, Fas, CD95/Apo‐1) gene promoter at rel/nuclear factor κB sites in prostatic carcinomaMolecular Carcinogenesis, 2001
- Cooperation between STAT3 and c-Jun Suppresses Fas TranscriptionMolecular Cell, 2001
- Surfing the p53 networkNature, 2000
- Molecular alterations in bladder cancer.Urological Research, 1998
- Protection from Fas-Mediated Apoptosis by a Soluble Form of the Fas MoleculeScience, 1994